Skip to main content

Pursue the right partner

Inpart is built to simplify your daily tasks, allowing you to spend more time on identifying and pursuing the right opportunities.

Request a demo

Custom and prebuilt integrations

Easily add meetings from BIO Convention, J. P. Morgan Healthcare Conference or emails from your Outlook into the system. Import new data about opportunities from databases like Evaluate Pharma and more.
Learn more about Integrations

Centralized partnering data

Find everything you need to know about a potential partner or asset in one place, accessible at any time.
Learn more about Deal

Secure and accessible

Improve collaborations with secure file storage. Simply drag and drop documents and emails to securely store and share with stakeholders.
Learn more about Deal

Implement S&E best practices

Inpart Deal helps our clients achieve partnering excellence through creating one place for all partnering interactions. It also allows teams to visualize and prioritize opportunities with reports are fast to create and easy to share.

Read case study
“Inpart is built exactly for what we do: pharma partnering. It helps us work together as one company. We started with just the S&E department, then quickly scaled the solution to add more teams such as the drug delivery and digital health teams. With everything in one place, we collaborate better together.”
Search & Evaluation Director
Novo Nordisk

From campaigns to evaluation

Results from Connect Campaigns are directly created in Deal without any manual data entry. Improve the way you triage results and request connections to potential partners.

About Inpart Connect
21 Days LeftSeeking Protein Technology for Conditionally-activated TherapeuticsA top five pharmaceutical company wishes to identify protein engineering technologies that support the development of...Read more21 Days LeftSeeking Novel Biology for Treatment of Immunology & Inflammation DiseasesA multinational pharmaceutical company is seeking novel targets and therapeutics for immunology and inflammation...Read more21 Days LeftNovel Therapeutic Approaches to Inhibit Type 2 InflammationBalsa Pharma Innovation is seeking novel therapeutic approaches to inhibit type 2 inflammation in atopic...Read more
Initech therapeutics - ITHR-8976StatusActiveOwned byJDJohn DoeFromInitech TherapeuticsJan, 22 2023Pre-CDA ReviewConfidential EvaluationJan, 20 2032IdentificationPre-CDA ReviewShare informations of company evaluationSep, 23 2022ALAlbertina LatiShare informations of company evaluationSep, 23 2022ALAlbertina Lati

Access partnering data

The system is preconfigured and tailored for life sciences partnering, centralizing all your partnership data seamlessly, from contacts to meetings, to documents. Its mobile access lets you quickly review past interactions, ensuring informed meetings on the go.

About Inpart Deal

Improve internal collaboration

Streamline team focus by clearly outlining your company’s objectives and strategy. Accelerate and standardize the review process with built-in evaluation templates.

About Inpart Deal
CommentsWrite a commentSend JD John Doe 5 min agoReply That's good to know. What's the current stage of their development, and do they have any existing partnerships? See replies 1 SB Sarah Brooks 5 min agoReply That’s great to know! Let’s set up a meeting with their team to discuss potential collaboration in more detail. , @Daniel @MayaJD John Doe 5 min agoReply , Lorem ipsum dolor sit amet, consectetur adipiscing elit. Donec quis magna sit amet dui accumsan. @SarahDS Daniel Smith 5 min agoReply they're currently focused on Phase II trials, and they haven't entered into any major partnerships yet. , @SarahSee replies 2

Integrations for Search & Evaluation

Outlook Add-in

Securely store and share your emails

Use the platform to effortlessly store and share your emails with the Outlook Add-in, updating and retrieving information with just a few clicks.

Evaluate Pharma Profiles

Get the latest biopharma intelligence from Evaluate Pharma

Enrich your opportunities with the latest intelligence from Evaluate Pharma. Our algorithms will automatically match your opportunities to existing companies or assets in Evaluate Pharma. From there you can easily view the latest intelligence right from your opportunity. Select key data from Evaluate Pharma company and asset profiles are included for all Inpart Deal users with a manager role.

External Opportunity Portal

Capture external innovation opportunities

Manage scattered, unsolicited emails and submissions from your corporate website with Inpart's Opportunity Portal. It offers a simple, efficient way to build a repository of all external opportunities, sort through them and find the most interesting ones.

Inpart Data

Create opportunities with Inpart proprietary data

When initiating a new opportunity, rely on Inpart Data, our dedicated database for biotechs looking for investments or out-licensing. It automatically populates essential fields like company description, financial data, and asset development information. By connecting opportunities to Inpart Data, information will be automatically updated on company and asset profiles, ensuring access to the most recent information to make informed decisions.

Simplify opportunity evaluation

Empower your team with the right tool to accelerate and standardize the review process with evaluation templates.

Get started

We help bring science to life.

Products
Connect
Deal
Event
Get started
Network
About
Global Challenges
Campaigns
Join the network
Platform
Holistic partnering
Connecting
Networking
Execution
Trust
Security & Compliance
Resources
Blog
Partnering insights
Labiotech.eu
Company
About us
Contact us
© 2025 Inpart Privacy policy Terms of use